Humana Inc. Enters Material Definitive Agreement

Ticker: HUM · Form: 8-K · Filed: 2025-03-05T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Humana signed a big deal on March 3rd, creating a new financial obligation.

AI Summary

On March 3, 2025, Humana Inc. entered into a material definitive agreement, which also created a direct financial obligation for the company. The filing does not provide specific details on the agreement or the financial obligation.

Why It Matters

This filing indicates a significant new agreement or financial commitment by Humana Inc., which could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — The nature of the material definitive agreement and the resulting financial obligation are not specified, creating uncertainty about potential risks.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Humana Inc. on March 3, 2025?

The filing states that Humana Inc. entered into a material definitive agreement on March 3, 2025, but does not provide specific details about its nature.

What is the direct financial obligation created by this agreement?

The filing confirms the creation of a direct financial obligation for Humana Inc. as a result of the agreement, but the specifics of this obligation are not disclosed.

When was this Form 8-K filed with the SEC?

This Form 8-K was filed on March 5, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive office is located at 500 W. Main Street, Louisville, Kentucky 40202.

What are the key items reported in this 8-K filing?

The key items reported are the entry into a material definitive agreement, the creation of a direct financial obligation, and other events, along with financial statements and exhibits.

From the Filing

0001628280-25-010583.txt : 20250305 0001628280-25-010583.hdr.sgml : 20250305 20250305171840 ACCESSION NUMBER: 0001628280-25-010583 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 25 CONFORMED PERIOD OF REPORT: 20250303 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250305 DATE AS OF CHANGE: 20250305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 25712439 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20250303.htm 8-K hum-20250303 0000049071 false 0000049071 2025-03-03 2025-03-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2025 ( March 3, 2025 ) Humana Inc.   (Exact name of registrant as specified in its charter) Delaware 001-05975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 W. Main Street , Louisville , Kentucky 40202   (Address of principal executive offices, and Zip Code) 502 - 580-1000   Registrant’s telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01.     Entry into a Material Definitive Agreement. Underwriting Agreement On March 3, 2025, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and U.S. Bancorp Investments, Inc., as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $750 million a

View on Read The Filing